OtherArticle
Antitumorigenic Effects of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Non-small Cell Lung Cancer Cells (NSCLC) are Mediated by Suppression of COX-2 via Inhibition of NF-κB
Yvette Bren-Mattison, Amy M Meyer, Vicki Van Putten, Howard Li, Katherine Kuhn, Robert Stearman, Mary Weiser-Evans, Robert A Winn, Lynn E Heasley and Raphael Nemenoff
Molecular Pharmacology November 30, 2007, DOI: https://doi.org/10.1124/mol.107.042002
Yvette Bren-Mattison
Amy M Meyer
Vicki Van Putten
Howard Li
Katherine Kuhn
Robert Stearman
Mary Weiser-Evans
Robert A Winn
Lynn E Heasley
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
Antitumorigenic Effects of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Non-small Cell Lung Cancer Cells (NSCLC) are Mediated by Suppression of COX-2 via Inhibition of NF-κB
Yvette Bren-Mattison, Amy M Meyer, Vicki Van Putten, Howard Li, Katherine Kuhn, Robert Stearman, Mary Weiser-Evans, Robert A Winn, Lynn E Heasley and Raphael Nemenoff
Molecular Pharmacology November 30, 2007, DOI: https://doi.org/10.1124/mol.107.042002
OtherArticle
Antitumorigenic Effects of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Non-small Cell Lung Cancer Cells (NSCLC) are Mediated by Suppression of COX-2 via Inhibition of NF-κB
Yvette Bren-Mattison, Amy M Meyer, Vicki Van Putten, Howard Li, Katherine Kuhn, Robert Stearman, Mary Weiser-Evans, Robert A Winn, Lynn E Heasley and Raphael Nemenoff
Molecular Pharmacology November 30, 2007, DOI: https://doi.org/10.1124/mol.107.042002
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement